Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scodari Joseph C
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HARRISON THOMAS L
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Donohue James J.
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DEAN JACK H
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LUCI DAVID P
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shawah Robert G.
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DELUCCIA ROBERT J
Acurx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LUCI DAVID P
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DELUCCIA ROBERT J
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Donohue James J.
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HARRISON THOMAS L
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DEAN JACK H
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scodari Joseph C
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
No Data